• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG GAV VALVE 5/30; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG GAV VALVE 5/30; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV310T
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Hydrocephalus (3272)
Event Date 09/16/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with the shunt system.The patient was initially implanted with a gav valve.Postoperatively, there was an unspecified dysfunction.Due to the malfunction, the valve was explanted on (b)(6) 2019.Additional information was not provided.
 
Manufacturer Narrative
Manufacturing evaluation: the valve was received dry (not submersed in liquid as suggested).Visual inspection - no significant deformations or damage of the valve were detected during the visual inspection.Permeability test - results have shown that the valve has a blockage.Adjustment test - this is a fixed pressure valve.An adjustment test is n/a.Braking force and function test - this test is n/a.Results - it should be noted that the valve was received dry (i.E.Not submersed in liquid as recommended).The investigation of dry items is not significant due to the affect dry deposits of liquor and blood can have on product performance.In spite of this, we have investigated the valve to the best of our abilities.After the tests, we have dismantled the valve.Inside the valve we found a build-up of substances (likely protein).Based on our investigation, we detect a presence of occlusion in the valve, likely due to the deposits observed inside the valve.As described in our literature, the problem encountered is one of the known, inevitable risks of hydrocephalus (hc) therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GAV VALVE 5/30
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9136837
MDR Text Key166157989
Report Number3004721439-2019-00252
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K031303
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2022
Device Model NumberFV310T
Device Catalogue NumberFV310T
Device Lot Number20035592
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/20/2019
Date Manufacturer Received09/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age2 YR
-
-